[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593154":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":17,"centralContacts":31,"locations":37,"responsibleParty":54,"collaborators":17,"id":58,"slug":17,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":17,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":17,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":17,"overallStatus":76,"whyStopped":17,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Patel Hospital, Pakistan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"A","ACTIVE_COMPARATOR","tranexamic acid",[13],"Drug: Tranexamic Acid (TXA)",{"label":15,"type":16,"description":17,"interventionNames":18},"B","PLACEBO_COMPARATOR",null,[19],"Device: Placebo",[21,26],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":17},"DRUG","Tranexamic Acid (TXA)","I would like to see the effect of prophylactic tranexamic acid in women undergoing ELLSCS in preventing PPH in my setup.",[9],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":17},"DEVICE","Placebo","one group will get placebo",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":17,"email":36},"NIMRA ABID","CONTACT","+92 3342430703","nimrachauhan12@gmail.com",[38],{"facility":39,"status":17,"city":40,"state":41,"zip":17,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Patel Hospital","Karachi","Sindh","Pakistan",{"type":44,"coordinates":45},"Point",[46,47],67.0104,24.8608,{"lat":47,"lon":46},[50],{"name":51,"role":34,"phone":52,"phoneExt":17,"email":53},"patel hospital erc commitee","+92 2138658894","erc@patel-hospital.com",{"type":55,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"PRINCIPAL_INVESTIGATOR","NIMRA ABID CHAUHAN","RESIDENT OBGYN","100593154",false,"NCT07002749","ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS","Inclusion Criteria:\n\n* Pregnant women with singleton pregnancy and low risk for PPH admitted for ELLSCS\n\nExclusion Criteria:\n\nWomen with medical disorder or complex pregnancy.\n\n* Women with history of PPH.\n* Women with bleeding disorder.\n* Abnormal placentation (MAP, placenta previa)\n* Multiple pregnancy.",true,"FEMALE","18 Years","45 Years",{"count":68,"type":69},104,"ESTIMATED","INTERVENTIONAL",[72],"PHASE1","IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEXAMIC ACID IN PREVENTING PPH.\n\nTHIS IS A RANDOMIZED CONTROLLED TRIAL. THE SAMPLING TECHNIQUE WOULD BE NON-PROBABILITY TECHNIQUE RANDOMIZATION WOULD BE DONE VIA BALLOTING METHOD.",[75],"Post Partum Hemorrhage","NOT_YET_RECRUITING","2025-05-25",{"date":79,"type":80},"2025-06-04","ACTUAL",{"date":82,"type":69},"2025-06-01",{"date":84,"type":69},"2025-12-31",{"name":5,"class":6},1]